Health Care Utilization and Costs Associated With Systemic First-Line Metastatic Melanoma Therapies in the United States.
van Boemmel-Wegmann S, Brown JD, Diaby V, Huo J, Silver N, Park H. Health Care Utilization and Costs Associated With Systemic First-Line Metastatic Melanoma Therapies in the United States. JCO Oncol Pract. 2022 01; 18(1):e163-e174.